GCC · Announced 21 Oct 2026
Department of Health – Abu Dhabi → Isomorphic Labs
Deal between Department of Health – Abu Dhabi (United Arab Emirates) and Isomorphic Labs (United Kingdom), announced 21 Oct 2026.
Parties: Department of Health – Abu Dhabi (United Arab Emirates) → Isomorphic Labs (United Kingdom)
- Deal type
- Other
- Value
- Not stated
- Territory
- United Arab Emirates
- Therapeutic area
- Other
- Asset
- 24-month roadmap for AI-enabled preclinical drug discovery conducted inside Abu Dhabi's Trusted Research Environment
- Announced
- 21 Oct 2026
Our analysis
Why this matters
Abu Dhabi is renting its data estate to the world's most closely watched AI drug discovery company. Isomorphic Labs — the Google DeepMind spinout developing AlphaFold-derived drug design models — will run a 24-month preclinical research roadmap inside the emirate's Trusted Research Environment, where data stays sovereign and the compute comes to it. For CEOs: this is the first sovereign-scale AI discovery deal in the region. For BD: Abu Dhabi's MGX fund already joined Isomorphic's US$2.1 billion funding round — this is a portfolio company deploying into the home market.
The full analysis is free to read with a work email on this page.